Smith Mark Douglas sold JAZZ
June 15, 2026 · Form 4 insider transaction
Smith Mark Douglas sold 1,157 shares of Jazz Pharmaceuticals plc at $230.55 per share, a transaction worth $266.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,157
Price
$230.55
Total value
$266.7K
InsiderSmith Mark Douglas
Role—
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateJune 15, 2026
Filing dateJune 17, 2026
Shares owned after9,680
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was made pursuant to a plan adopted by the reporting person on March 9, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.